MedTrace Logo

Central Nervous System Stimulants and Physical Function in Children With Cerebral Palsy

NCT05675098 · Status: NOT_YET_RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-03-08

No results posted yet for this study

Summary

The purpose of this study is to determine the effects of Central Nervous System Stimulants, represented by Methylphenidate and Modafinil, compared to placebo control on motor performance in children with Cerebral Palsy. This study will be a triple-masked study per the American Academy of Neurology guidelines for clinical trials.

Conditions

  • Neurodevelopmental Disorders
  • Cerebral Palsy

Interventions

DRUG

Methylphenidate

This medication is a psychostimulant medication and is usually prescribed for individuals with Attention-Deficit/Hyperactivity Disorder to manage ADHD behavioral symptoms

DRUG

Modafinil

This medication is a Central Nervous System stimulant and is usually used to treat neurological conditions, including Narcolepsy

OTHER

Placebo

Participant will receive placebo tablets (Methylphenidate and Modafinil shape)

Sponsors & Collaborators

  • Kuwait University

    lead OTHER

Principal Investigators

  • Anwar B Almutairi, PT, PhD · Kuwait University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
7 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-02-01
Completion
2027-02-01

Countries

  • Kuwait

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05675098 on ClinicalTrials.gov